Profile data is unavailable for this security.
About the company
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Its Diagnostics segment offers a range of diagnostics products, such as ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Its Breast Health segment offers a portfolio of solutions for breast cancer care, primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment offers a range of products, such as NovaSure Endometrial Ablation System, MyoSure Hysteroscopic Tissue Removal System and Fluent Fluid Management system as well as its Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, and the Fluoroscan Insight FD mini C-arm.
- Revenue in USD (TTM)4.86bn
- Net income in USD1.30bn
- Incorporated1990
- Employees6.94k
- LocationHologic Inc250 Campus DriveMARLBOROUGH 1752United StatesUSA
- Phone+1 (781) 999-7300
- Fax+1 (302) 655-5049
- Websitehttps://www.hologic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein, Inc. | 12.61bn | 638.23m | 10.93bn | 21.60k | 17.55 | 3.02 | 12.54 | 0.8671 | 4.59 | 4.59 | 90.74 | 26.70 | 1.49 | 4.88 | 8.24 | 583,635.30 | 7.70 | 6.27 | 12.99 | 11.21 | 30.23 | 29.99 | 5.18 | 4.80 | 0.9967 | 36.38 | 0.1785 | 0.00 | 22.55 | 1.39 | 56.71 | 4.49 | 2.40 | -- |
| Teleflex Incorporated | 2.79bn | 412.27m | 11.07bn | 14.00k | 27.11 | 2.84 | 17.24 | 3.96 | 8.71 | 8.71 | 59.02 | 83.04 | 0.4051 | 2.50 | 7.07 | 199,639.90 | 5.98 | 5.57 | 6.53 | 6.10 | 54.70 | 55.22 | 14.75 | 13.90 | 1.52 | 11.29 | 0.3048 | 17.97 | 10.74 | 8.51 | 44.47 | 15.39 | 6.15 | 0.00 |
| Align Technology, Inc. | 3.86bn | 510.76m | 14.53bn | 22.54k | 28.80 | 3.93 | 22.98 | 3.76 | 6.46 | 6.46 | 48.97 | 47.30 | 0.6684 | 4.18 | 4.51 | 171,438.30 | 8.83 | 25.12 | 12.83 | 36.50 | 71.44 | 73.40 | 13.22 | 30.36 | 1.20 | -- | 0.00 | 0.00 | 59.90 | 29.63 | -56.53 | 32.41 | 41.55 | -- |
| Cooper Companies Inc | 3.22bn | 430.60m | 15.45bn | 12.00k | 36.23 | 2.18 | 20.19 | 4.80 | 8.64 | 8.64 | 64.62 | 143.67 | 0.3043 | 1.84 | 5.97 | 268,291.70 | 4.07 | 14.09 | 4.60 | 15.99 | 65.38 | 65.03 | 13.37 | 34.48 | 0.7095 | 63.36 | 0.2892 | 0.3386 | 20.22 | 8.24 | 1,135.19 | 60.80 | 7.03 | 0.00 |
| ABIOMED Inc | 1.07bn | 266.76m | 17.04bn | 2.00k | 64.96 | 11.09 | 57.90 | 15.87 | 5.82 | 5.82 | 23.41 | 34.09 | 0.6658 | 2.13 | 11.67 | 536,243.60 | 16.54 | 16.91 | 17.91 | 18.75 | 81.32 | 82.13 | 24.84 | 23.45 | 7.17 | -- | 0.00 | 0.00 | 21.74 | 18.30 | -39.47 | 21.24 | -6.64 | -- |
| West Pharmaceutical Services Inc. | 2.91bn | 633.80m | 17.40bn | 10.07k | 28.29 | 7.04 | 23.50 | 5.98 | 8.31 | 8.27 | 38.11 | 33.39 | 0.9007 | 4.52 | 6.05 | 289,021.40 | 19.08 | 14.11 | 22.64 | 16.78 | 40.45 | 35.61 | 21.19 | 16.01 | 2.89 | 280.86 | 0.0781 | 13.61 | 31.89 | 13.41 | 90.76 | 35.68 | 8.29 | 7.09 |
| Hologic, Inc. | 4.86bn | 1.30bn | 18.25bn | 6.94k | 14.50 | 3.76 | 10.53 | 3.75 | 5.12 | 5.12 | 19.16 | 19.73 | 0.5406 | 3.29 | 6.23 | 700,273.60 | 14.47 | 9.46 | 16.56 | 11.38 | 62.00 | 59.98 | 26.78 | 17.39 | 3.45 | 38.69 | 0.3684 | 0.00 | -13.66 | 9.72 | -30.43 | 11.50 | 3.40 | -- |
| Steris PLC | 4.78bn | -8.14m | 18.32bn | 16.42k | -- | 3.16 | 29.80 | 3.84 | -0.1063 | -0.1063 | 47.49 | 58.10 | 0.4295 | 4.33 | 6.19 | 290,869.90 | -0.0839 | 5.33 | -0.0907 | 5.84 | 45.22 | 43.08 | -0.1953 | 10.08 | 1.42 | 7.62 | 0.3423 | 39.11 | 47.55 | 11.90 | -38.63 | 17.27 | 10.71 | 9.17 |
| Insulet Corporation | 1.24bn | 16.80m | 20.83bn | 2.30k | 1,359.99 | 48.66 | 264.70 | 16.76 | 0.2206 | 0.2206 | 17.68 | 6.16 | 0.597 | 1.51 | 7.88 | 540,565.20 | 0.8067 | 0.1989 | 0.9327 | 0.2255 | 64.47 | 65.32 | 1.35 | 0.3174 | 3.00 | 2.24 | 0.7667 | 0.00 | 21.49 | 24.52 | 147.06 | -- | 40.87 | -- |
| Zimmer Biomet Holdings Inc | 7.15bn | 338.40m | 25.47bn | 19.50k | 75.55 | 2.08 | 19.53 | 3.56 | 1.61 | 1.32 | 34.08 | 58.36 | 0.3155 | 0.9301 | 5.36 | 366,805.10 | 1.50 | 1.03 | 1.69 | 1.16 | 69.79 | 71.16 | 4.74 | 3.31 | 1.05 | 7.20 | 0.3181 | 77.35 | 11.56 | 0.4339 | 400.00 | 7.13 | -1.88 | 0.00 |
| Baxter International Inc | 14.74bn | -2.38bn | 25.97bn | 60.00k | -- | 4.69 | -- | 1.76 | -4.72 | -4.72 | 29.10 | 10.98 | 0.6171 | 3.99 | 6.37 | 245,666.70 | -9.90 | 6.03 | -11.66 | 7.22 | 36.38 | 41.58 | -16.04 | 10.02 | 1.38 | 5.22 | 0.7465 | 38.31 | 9.52 | 4.70 | 16.52 | -23.70 | 0.6589 | 16.53 |
Data as of Dec 07 2022. Currency figures normalised to Hologic Inc's reporting currency: US Dollar USD
44.27%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2022 | 27.42m | 10.98% |
| T. Rowe Price Investment Management, Inc.as of 30 Sep 2022 | 24.65m | 9.87% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 15.07m | 6.04% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 11.55m | 4.63% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 2022 | 7.25m | 2.91% |
| Geode Capital Management LLCas of 30 Sep 2022 | 5.83m | 2.34% |
| Macquarie Investment Management Business Trustas of 30 Sep 2022 | 5.83m | 2.34% |
| Wellington Management Co. LLPas of 30 Sep 2022 | 4.69m | 1.88% |
| Victory Capital Management, Inc. (Investment Management)as of 30 Sep 2022 | 4.27m | 1.71% |
| Arrowstreet Capital LPas of 30 Sep 2022 | 3.96m | 1.59% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
